Science 37 Holdings, Inc.
SNCE · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $15 | $15 | $14 | $16 |
| % Growth | -3% | 9% | -11.6% | – |
| Cost of Goods Sold | $9 | $10 | $11 | $12 |
| Gross Profit | $6 | $5 | $3 | $4 |
| % Margin | 39.7% | 35.1% | 21.1% | 22.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $15 | $17 | $20 | $20 |
| Sales & Mktg Exp. | $15 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $5 |
| Operating Expenses | $15 | $17 | $21 | $26 |
| Operating Income | -$15 | -$20 | -$18 | $23 |
| % Margin | -97.7% | -132.9% | -125.8% | 146.9% |
| Other Income/Exp. Net | $1 | $1 | -$7 | -$44 |
| Pre-Tax Income | -$14 | -$20 | -$25 | -$67 |
| Tax Expense | $0 | $0 | -$1 | -$0 |
| Net Income | -$14 | -$20 | -$24 | -$67 |
| % Margin | -93.5% | -127.5% | -166.9% | -417.4% |
| EPS | -0.12 | -0.17 | -0.2 | -0.57 |
| % Growth | 29.4% | 15% | 64.9% | – |
| EPS Diluted | -0.12 | -0.17 | -0.2 | -0.57 |
| Weighted Avg Shares Out | 118 | 117 | 116 | 116 |
| Weighted Avg Shares Out Dil | 118 | 117 | 116 | 116 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $90 |
| Depreciation & Amortization | $0 | $0 | $8 | $5 |
| EBITDA | -$3 | -$2 | -$10 | $29 |
| % Margin | -22% | -14% | -68% | 180.6% |